Skip to content
LocateCongress
Official portrait of David Valadao, U.S. Representative for California's 22nd District

David Valadao

U.S. Representative for California's 22nd District

Republican · Since 2021 · Next election: 2026 · Age 49

Official name: David G. Valadao

Last updated · 7 sources

David Valadao is the U.S. Representative for California's 22nd District, a Republican serving since 2021.

Valadao has served in the House longer than 161 of its 438 other members and longer than 16 of California's 51 other House members.

Valadao sits on 3 committees: Congress on the Library, Agriculture, and Appropriations.

In the House's last 30 days in session (May 19 – Oct 2, 2026), Valadao voted in 139 of 139 roll calls (100%). In that period, 65 bills Valadao sponsored or cosponsored had new actions.

Valadao has filed with the FEC to run for this seat in 2026. 4 candidates for the seat have reported receipts to the FEC.

This week (Sep 28 – Oct 4, 2026)

Full schedule →

House: pro forma sessions Mon and Thu

Votes

All of them →

Voted in 139 of 139 roll calls (100%), May 19 – Oct 2, 2026.

Valadao voted with the majority of House Republicans on 136 roll calls and against it on 3.

Votes against the party majority

David Valadao's most recent votes against the party majority and missed votes
DateVoteQuestionResultDavid ValadaoNote
Jul 22No. 276On Agreeing to the Amendment H.R. 8800FailedNayMost House Republicans: Yea
Jul 15No. 245On Agreeing to the Amendment H.R. 8595FailedNayMost House Republicans: Yea
Jul 15No. 242On Agreeing to the Amendment H.R. 8595FailedNayMost House Republicans: Yea

Legislation

36 bills sponsored and 331 cosponsored in the 119th Congress

  • H.R. 9340 Ratepayer Protection Act

    Cosponsor · Latest action Sep 30, 2026: Motion to proceed to consideration of measure withdrawn in Senate.

  • H.R. 8205 Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

    Cosponsor · Latest action Sep 28, 2026: Passed Senate without amendment by Voice Vote. (consideration: CR S5120)

    This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases.

  • H.R. 10626 HELP STATES Act

    Cosponsor · Latest action Sep 28, 2026: Referred to the House Committee on Energy and Commerce.

Campaign finance

Raised
$4,927,602
Spent
$1,607,550
Cash on hand
$3,365,587

2026 election cycle, through Jun 30, 2026 · FEC H2CA20094

California senators

All 54 members of Congress from California →

Sources